Adrienne Howard

402 total citations
11 papers, 237 citations indexed

About

Adrienne Howard is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, Adrienne Howard has authored 11 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 6 papers in Hematology and 3 papers in Genetics. Recurrent topics in Adrienne Howard's work include Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). Adrienne Howard is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). Adrienne Howard collaborates with scholars based in United States. Adrienne Howard's co-authors include Joya Chandra, Yin Gao, Kechen Ban, Aung Naing, Jennifer J. Wheler, Razelle Kurzrock, David S. Hong, Gerald S. Falchook, Hesham M. Amin and Raymond E. Meyn and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Adrienne Howard

11 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrienne Howard United States 8 119 59 58 45 37 11 237
R.G.P. Queiroz Brazil 9 106 0.9× 86 1.5× 43 0.7× 24 0.5× 27 0.7× 18 248
Raoul Santiago Canada 8 57 0.5× 19 0.3× 59 1.0× 25 0.6× 56 1.5× 22 254
G. J. Dovey United Kingdom 8 165 1.4× 149 2.5× 72 1.2× 29 0.6× 127 3.4× 10 369
Alexey Moisseev Russia 7 139 1.2× 34 0.6× 123 2.1× 45 1.0× 21 0.6× 11 289
Mairead MacKenzie United Kingdom 9 38 0.3× 32 0.5× 78 1.3× 85 1.9× 40 1.1× 26 296
Miguel Franquiz United States 7 76 0.6× 41 0.7× 59 1.0× 46 1.0× 197 5.3× 11 279
Desmond Robb Canada 7 91 0.8× 14 0.2× 141 2.4× 36 0.8× 43 1.2× 9 328
Shenglan Gong China 11 286 2.4× 46 0.8× 118 2.0× 36 0.8× 180 4.9× 30 447
Jayeshkumar Patel United States 10 79 0.7× 15 0.3× 47 0.8× 16 0.4× 21 0.6× 21 221
Kanyalakshmi Ayyanar United States 7 214 1.8× 11 0.2× 83 1.4× 35 0.8× 52 1.4× 10 351

Countries citing papers authored by Adrienne Howard

Since Specialization
Citations

This map shows the geographic impact of Adrienne Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrienne Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrienne Howard more than expected).

Fields of papers citing papers by Adrienne Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrienne Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrienne Howard. The network helps show where Adrienne Howard may publish in the future.

Co-authorship network of co-authors of Adrienne Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Adrienne Howard. A scholar is included among the top collaborators of Adrienne Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrienne Howard. Adrienne Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Falchook, Gerald S., Jennifer J. Wheler, Aung Naing, et al.. (2014). Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab. Oncotarget. 5(21). 10280–10292. 47 indexed citations
2.
Fu, Siqing, Aung Naing, Jennifer J. Wheler, et al.. (2013). Barriers to Study Enrollment in Patients With Advanced Cancer Referred to a Phase I Clinical Trials Unit. The Oncologist. 18(12). 1315–1320. 18 indexed citations
3.
Singh, Melissa, Adrienne Howard, Mary E. Irwin, et al.. (2012). Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia. PLoS ONE. 7(12). e51611–e51611. 22 indexed citations
4.
Fu, Siqing, Fedricker Diane Barber, Aung Naing, et al.. (2012). Advance Care Planning in Patients With Cancer Referred to a Phase I Clinical Trials Program: The MD Anderson Cancer Center Experience. Journal of Clinical Oncology. 30(23). 2891–2896. 22 indexed citations
5.
Fu, Siqing, David S. Hong, Aung Naing, et al.. (2011). Outcome Analyses After the First Admission to an Intensive Care Unit in Patients With Advanced Cancer Referred to a Phase I Clinical Trials Program. Journal of Clinical Oncology. 29(26). 3547–3552. 22 indexed citations
6.
Fu, Siqing, David S. Hong, Aung Naing, et al.. (2011). Outcome analyses after the first admission to an intensive care unit in patients with cancer enrolled into a phase I clinical trials program: When is the optimal time to trigger code status discussion?. Journal of Clinical Oncology. 29(15_suppl). e13020–e13020. 1 indexed citations
7.
Lü, Xiaolin, Adrienne Howard, Yin Gao, Melissa Singh, & Joya Chandra. (2010). Abstract 1627: Requirement for the Src family kinase, Fyn, in proliferation of BCR-ABL1 transduced bone marrow and aneuploidy in CML. Cancer Research. 70(8_Supplement). 1627–1627. 1 indexed citations
8.
Gao, Yin, Adrienne Howard, Kechen Ban, & Joya Chandra. (2009). Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells. Journal of Biological Chemistry. 284(11). 7114–7125. 35 indexed citations
9.
Howard, Adrienne, Kathleen A. Bridges, Raymond E. Meyn, & Joya Chandra. (2009). ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress. Cancer Chemotherapy and Pharmacology. 65(1). 41–54. 26 indexed citations
10.
Ban, Kechen, Yin Gao, Hesham M. Amin, et al.. (2008). BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia. Blood. 111(5). 2904–2908. 42 indexed citations
11.
Chandra, Joya, Hesham M. Amin, Adrienne Howard, et al.. (2006). Fyn Upregulation Is a Novel ROS-Dependent Mechanism Controlling CML Growth, Progression and Imatinib Resistance.. Blood. 108(11). 2241–2241. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026